The key point: Barcelona-based STE Pharmaceuticals plans to open a production and R&D site in Couvet (NE) by 2032.
The bill
- A dedicated entity, STE Swiss Pharma, is leading the move to Switzerland.
- The group will convert the former Analytecon plant, with partial demolition.
- The public consultation on the building permit runs until 9 November.
The company
- The Catalan group operates in more than 60 countries.
- It makes nasal sprays, cough syrups and natural food supplements.
- The number ofskilled jobs to be created has not yet been quantified.
A hub in Val-de-Travers
- Couvet already hosts three pharmaceutical companies.
- The canton sees the beginnings of a cluster attractive to skilled labour.
Key figures
- 15,000 m² : planned construction area
- 2032 : target date for the site
- 60 : number of countries where the group operates
In short
STE Pharmaceuticals is converting a former factory in Couvet into an industrial and research site. The canton of Neuchâtel sees it as a way to diversify the Val-de-Travers economy.
